Accuracy of Clinical Staging in Early-Stage Pancreatic Ductal Adenocarcinoma

JAMA. 2024 Oct 1;332(13):1108-1110. doi: 10.1001/jama.2024.16332.

Authors

Gerardo Perrotta¹, Ghada Mohamed¹, Brent K Larson², Arsen Osipov³, Cristina R Ferrone⁴, Simon K Lo¹, Srinivas Gaddam¹

Affiliations

¹ Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California.
² Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
³ Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
⁴ Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.

No abstract available

Plain language summary

This study evaluates the accuracy of clinical staging in early-stage pancreatic ductal adenocarcinoma.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Carcinoma, Pancreatic Ductal* / diagnosis
Carcinoma, Pancreatic Ductal* / mortality
Carcinoma, Pancreatic Ductal* / pathology
Carcinoma, Pancreatic Ductal* / therapy
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging*
Pancreas / pathology
Pancreas / surgery
Pancreatectomy
Pancreatic Neoplasms* / diagnosis
Pancreatic Neoplasms* / mortality
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / therapy
Risk Assessment